Ilya Pharma is a clinical stage biopharmaceutical company developing next generation immunotherapies to treat wounds in skin and mucosa. A spin-out pharmaceutical company from several years of research at Uppsala University and the Swedish University of Agriculture. The company is currently pursuing three projects with drug candidates from its proprietary ILP-technology platform to clinical proof of concept and validation.